Find the nearest Life Pharmacy where this item is available Overview Wegovy 4mg Tablets are a prescription-only, once-daily oral GLP-1 receptor agonist treatment containing semaglutide, developed by Novo Nordisk to support adults living with obesity or overweight with weight-related health conditions
If youve been wondering what GLP-1 really is, how it works in your body, and whether you actually need injections or can support it through lifestyle, you're not alone
As a lyophilised peptide, retatrutide must be stored at -20C and reconstituted carefully to preserve structural integrity
These formulations primarily target postprandial glucose control due to their shorter half-lives
Findings were similar in a trial with the Wegovy tablets
By activating GLP-1 receptors, semaglutide helps the pancreas release insulin when needed, lowers glucagon secretion, and slows the movement of food from the stomach into the intestine